HIV-1 gp120 neurotoxicity proximally and at a distance from the point of exposure: Protection by rSV40 delivery of antioxidant enzymes
- 30 June 2009
- journal article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 34 (3), 462-476
- https://doi.org/10.1016/j.nbd.2009.03.003
Abstract
No abstract availableThis publication has 78 references indexed in Scilit:
- Dementia and Neurocognitive Disorders Due to HIV-1 InfectionSeminars in Neurology, 2007
- Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler miceBMC Neuroscience, 2006
- Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosisGene Therapy, 2006
- Axonal Transport of Human Immunodeficiency Virus Type 1 Envelope Protein Glycoprotein 120 Is Found in Association with Neuronal ApoptosisJournal of Neuroscience, 2006
- Recombinant AAV Viral Vectors Pseudotyped with Viral Capsids from Serotypes 1, 2, and 5 Display Differential Efficiency and Cell Tropism after Delivery to Different Regions of the Central Nervous SystemMolecular Therapy, 2004
- Striatal Volume Changes in the Rat Following Long-term Administration of Typical and Atypical Antipsychotic DrugsNeuropsychopharmacology, 2002
- Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatumBrain Research, 2000
- Gene Transfer to Rodent Brain with Recombinant Adenoviral Vectors: Effects of Infusion Parameters, Infectious Titer, and Virus Concentration on Transduction VolumeExperimental Neurology, 1998
- HIV-1 gp120-induced neurotoxicity to midbrain dopamine culturesBrain Research, 1995
- Time profile of calcium accumulation in hippocampus, striatum and frontoparietal cortex after transient forebrain ischemia in the gerbilActa Neuropathologica, 1992